Anlon Healthcare Q1FY27: Revenue up 163%, PAT up 133%

Anlon Healthcare Limited reported strong unaudited consolidated financial results for Q1FY27, with Total Income surging 163.02% to ₹87.62 Cr, EBITDA growing 150.14% to ₹15.65 Cr, and PAT increasing 133.13% to ₹8.28 Cr. The company also announced strategic developments including the acquisition of a 63.98% stake in Remember India Health Links Pvt. Ltd., marking its entry into the Finished Dosage Formulations (FDF) segment. This expansion broadens its product portfolio and market presence, strengthening its integrated pharmaceutical platform. Management expressed confidence in achieving long-term revenue CAGR of 30% and maintaining EBITDA margins of 25%-30%.